Grail announced the completion of its separation from Illumina on June 24, 2024. Following the spin-off, the company expects to recognize significant impairment charges in Q2 2024, including a full goodwill impairment of $888.9 million, representing the entire remaining carrying value as of March 31, 2024.The company also anticipates recording an impairment charge of approximately $420 million for in-process research and development (IPR&D) intangible assets, as disclosed by Illumina. As of March 31, 2024, Grail's IPR&D intangible assets totaled $560 million. These impairments are related to pushdown accounting from Illumina's 2021 acquisition of Grail.The company does not expect any material future cash expenditures related to these impairments and will provide additional details in its Q2 2024 Form 10-Q filing. Grail continues to monitor for potential further impairment indicators in the second quarter.

Grail announced the completion of its separation from Illumina on June 24, 2024. Following the spin-off, the company expects to recognize significant impairment charges in Q2 2024, including a full goodwill impairment of $888.9 million, representing the entire remaining carrying value as of March 31, 2024.The company also anticipates recording an impairment charge of approximately $420 million for in-process research and development (IPR&D) intangible assets, as disclosed by Illumina. As of March 31, 2024, Grail's IPR&D intangible assets totaled $560 million. These impairments are related to pushdown accounting from Illumina's 2021 acquisition of Grail.The company does not expect any material future cash expenditures related to these impairments and will provide additional details in its Q2 2024 Form 10-Q filing. Grail continues to monitor for potential further impairment indicators in the second quarter.